Possible searches include drugs or medicines (by brand, generic ingredient or drug class), diseases, and more.
The FDA has issued a Complete Response Letter for its supplemental Biologics License Application (sBLA) for Opdivo (nivolumab), from BMS, as...
The German Institute for Quality and Efficiency in Health Care (IQWiG) has examined in a dossier assessment whether the fixed-dose...
The German Institute for Quality and Efficiency in Health Care (IQWiG) examined in a dossier assessment whether Keytruda (pembrolizumab),...
A FREE CME activity: ‘Best Practice in Type 2 Diabetes: Update on Incretin Therapies in Combination with Insulin’ is now available to complete on EPGonline.org
Go to CME >